Sign Up to like & get
recommendations!
0
Published in 2019 at "IDCases"
DOI: 10.1016/j.idcr.2019.e00634
Abstract: Ceftazidime–avibactam is a combination agent consisting of the β-lactamase inhibitor avibactam and the broad-spectrum cephalosporin ceftazidime. There are no published case reports or studies evaluating the use of CAZ-AVI in pediatric critically ill patients. We…
read more here.
Keywords:
ceftazidime avibactam;
pediatric critically;
successful treatment;
critically ill ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "International journal of antimicrobial agents"
DOI: 10.1016/j.ijantimicag.2018.07.027
Abstract: In Pseudomonas aeruginosa (P. aeruginosa) collected from cystic fibrosis (CF) patients, 24% resistance to ceftazidime-avibactam in isolates negative for carbapenemases and extended-spectrum β-lactamases (ESBLs) has previously been observed. The current study aimed to unravel the…
read more here.
Keywords:
ceftazidime avibactam;
mexab oprm;
avibactam;
Sign Up to like & get
recommendations!
1
Published in 2020 at "Journal of global antimicrobial resistance"
DOI: 10.1016/j.jgar.2020.08.004
Abstract: OBJECTIVES This study reports on the activity of aztreonam-avibactam against a collection of Klebsiella pneumoniae collected in 2016 and 2017. METHODS Non-duplicate isolates of K. pneumoniae were collected from four regions (Africa/Middle East, n=785; Asia-Pacific,…
read more here.
Keywords:
culture sources;
aztreonam avibactam;
pneumoniae collected;
activity ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.8b01389
Abstract: Only one FDA-approved β-lactamase inhibitor has ever been orally available: clavulanic acid, approved in 1984. Avibactam, approved by FDA in 2015, is the first of a new class of BLIs called diazabicyclooctanes, or "DBOs". This…
read more here.
Keywords:
inhibitor;
clavulanic acid;
lactamase inhibitor;
orally absorbed ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of Antimicrobial Chemotherapy"
DOI: 10.1093/jac/dkw546
Abstract: Objectives Mycobacterium tuberculosis and Mycobacterium abscessus produce broad-spectrum class A β-lactamases, BlaC and Bla Mab , which are inhibited by clavulanate and avibactam, respectively. BlaC differs from Bla Mab at Ambler position 132 in the…
read more here.
Keywords:
clavulanate;
bla mab;
avibactam;
inhibition ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofy210.1253
Abstract: Abstract Background The new β-lactamase inhibitor, avibactam (AVI), has recently been combined with ceftazidime (CAZ) as CAZ-AVI. AVI is also in Phase 3 clinical trials combined with aztreonam as ATM-AVI. Both drug combinations have similar…
read more here.
Keywords:
100 100;
caz avi;
atm avi;
avi ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.00592-18
Abstract: Enterobacteriaceae producing the Ambler class D OXA-48 carbapenemase, combined with additional resistance mechanisms, such as permeability defects or cocarriage of class A, B, or C β-lactamases, can become highly resistant to most β-lactams currently in…
read more here.
Keywords:
ceftazidime avibactam;
methodology;
aztreonam avibactam;
resistance ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of Clinical Microbiology"
DOI: 10.1128/jcm.00004-22
Abstract: Ceftazidime-avibactam (CZA), a novel β-lactam/β-lactamase inhibitor combination, has good antibacterial activity against carbapenem-resistant Enterobacterales (CRE) producing class A and C and some class D carbapenemases, but in recent years, the emergence of CZA-resistant Enterobacterales bacteria…
read more here.
Keywords:
rapid resaceftazidime;
resaceftazidime avibactam;
cza;
ceftazidime avibactam ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2019 at "mSphere"
DOI: 10.1128/msphere.00024-19
Abstract: The recent introduction of novel β-lactam/β-lactamase inhibitor combinations like ceftazidime-avibactam has increased our ability to treat infections caused by multidrug-resistant Gram-negative bacteria, including carbapenemase-producing Enterobacterales. However, the increasing number of cases of reported resistance to…
read more here.
Keywords:
ceftazidime avibactam;
caz;
resistance;
effect ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2022 at "Microbiology Spectrum"
DOI: 10.1128/spectrum.03733-22
Abstract: Klebsiella pneumoniae is one of the main bacteria that cause infections in health care settings. This pathogen has developed a high level of resistance to many antibiotics. ABSTRACT We describe an outbreak of Klebsiella pneumoniae…
read more here.
Keywords:
kpc;
avibactam;
klebsiella pneumoniae;
ceftazidime avibactam ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Microbiology"
DOI: 10.3389/fmicb.2022.1047109
Abstract: Aztreonam-avibactam is a promising combination to treat carbapenem-resistant Enterobacterales including coverage for metallo-β-lactamases. Escherichia coli strains resistant to aztreonam-avibactam have emerged but resistance mechanisms remain to be elucidated. We performed a study to investigate the…
read more here.
Keywords:
aztreonam avibactam;
escherichia coli;
pbp3;
avibactam ... See more keywords